300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Medical
Venture Capital
Fashion
Beauty
Social
Infrastructure
LGBT
Cannabis
Climate
Celebrity
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Music
Sporting Goods
Real Estate
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
Ireland
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Senegal
El Salvador
Tanzania
Sierra Leone
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Barbados
Belgium
Bangladesh
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Estonia
Faroe Islands
Jersey
Bahrain
Ecuador
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Bahamas
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Honduras
Iceland
Cambodia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Nicolas Weber, Angel Investor

Nicolas Weber

Angel Investor

Berlin, Germany

Nicolas Weber is a seed investor in Berlin focused on Genetics and Oncology. Healthcare has been my passion throughout most of my professional life – in international corporate environments and as entrepreneur and Business Angel. I co-founded medneo (https://www.medneo.com/) (Radiology as a Service) and OpenRad (https://www.openrad.com/) (IT rails for diagnostic imaging) and helped to buildit from zero to 550+ people – what a journey. I recently transitioned from Group CEO to the supervisory board. With medneo (https://www.medneo.com/) we are improving access to high-end diagnostic imaging (e.g. MRI, CT, etc.) for patients with a new pan-European operating model for medical service providers: Radiology as a Service. And with OpenRad (https://www.openrad.com/) we bring workflow IT to 3rd party diagnostic centers beyond medneo. I have developed the organization for CEOs to manage the brands independently and I support them actively as board director. Together with my two co-founders André Glardon (https://www.linkedin.com/in/andreglardon/) and Matthias Issing (https://www.linkedin.com/in/matthias-issing/) we – 3minds (https://www.linkedin.com/company/3minds-projects/) – are supporting outstanding impact entrepreneurs on their journey to improve our lives - as angels, mentors and in board functions. We engage directly and via amazing networks like Better Ventures (https://www.betterventures.io/) and Springboard Health (https://www.springboardangels.com/). I'm a grateful member of the Entrepreneurs' Organization (https://eonetwork.org) - the meaningful connections with diverse and inspiring people helped me to grow as a person. Also, I'm a board member of EO's Berlin Chapter (https://www.eoberlin.com/). Berlin (https://goo.gl/maps/6zP6kaWtrY7VQhvu6) based. Originally from the south of Germany (Pforzheim), had the opportunity to live and work abroad (e.g. USA, UK, China). I like endurance sports, especially long-distance running (Marathon+) and cycling. I'm happy to contribute and connect (https://about.me/nicolas.weber) - feel free to reach out! https://www.linkedin.com/in/nicolasweber/

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Nicolas Weber invests in

GeneticsOncologyHealth CareBiotechnologyGenerative AI

Stages Nicolas Weber invests in

SeedPre-Seed

Countries Nicolas Weber invests in

SwitzerlandUnited Kingdom

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Genetics 1 (50%)
  • Oncology 1 (50%)
  • Health Care 1 (50%)
  • Biotechnology 1 (50%)
  • Generative AI 1 (50%)
See all 7 industries →

Stage

  • Seed 1 (50%)
  • Pre-Seed 1 (50%)

Country

  • Switzerland 1 (50%)
  • United Kingdom 1 (50%)

Investments

CompanyDescriptionRoundLinks
At CGC Genomics (CGC) we are deeply committed to advancing the field of cancer care through complex, precision genomics analysis and report interpretation. We distill complex genomic data into concise, actionable insights for healthcare providers, reducing interpretation times and facilitating timely, personalized treatment recommendations for 10million patients with metastatic cancer.​ Our years of experience interpreting and supporting thousands of the most complicated cancer genomics cases around the world enables CGC to offer healthcare providers timely, expert cancer genomics analysis and consultation support, delivering world-class expertise wherever and whenever needed. $1.9M / Pre-Seed / Apr 14, 2025
Sanome are combining different types of biomarkers to develop engaging, useful and accurate diagnostic products (IVDs) that enable early detection and prevention of disease. The IVD innovation engine, will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms for all people. Seed / Jan 01, 2024

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Medical
Venture Capital
Fashion
Beauty
Social
Infrastructure
LGBT
Cannabis
Climate
Celebrity
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Music
Sporting Goods
Real Estate
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
Ireland
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Senegal
El Salvador
Tanzania
Sierra Leone
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Barbados
Belgium
Bangladesh
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Estonia
Faroe Islands
Jersey
Bahrain
Ecuador
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Bahamas
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Honduras
Iceland
Cambodia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Nicolas Weber invest in?

Nicolas Weber invests primarily in Genetics, Oncology and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 2 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Nicolas Weber?

Public channels for Nicolas Weber include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Nicolas Weber last invest?

The most recent investment recorded for Nicolas Weber closed in Apr 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Nicolas Weber Nicolas Weber Find email